Andrew Hill Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.93M Sell
21,806
-7,111
-25% -$1.02M 3.97% 12
2022
Q2
$4.43M Sell
28,917
-4,648
-14% -$710K 6.36% 3
2022
Q1
$5.44M Sell
33,565
-2,796
-8% -$406K 6.04% 2
2021
Q4
$4.92M Buy
+36,361
New +$4.3M 4.6% 3

Other funds holding ABBV

Andrew Hill Investment Advisors's ABBV Position: Q3 2022 in Review

Andrew Hill Investment Advisors reduced its AbbVie (ABBV) stake by 25% in Q3 2022, selling an estimated $1.02M and leaving 21,806 shares worth $2.93M. The position accounts for 3.97% of the portfolio, ranked #12.

Andrew Hill Investment Advisors first reported a position in ABBV in Q4 2021 and has held it in 4 quarters since. The position peaked at $5.44M in Q1 2022. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Andrew Hill Investment Advisors held 21,806 shares of AbbVie worth $2.93M as of Q3 2022.
  • Andrew Hill Investment Advisors sold 7,111 AbbVie shares in Q3 2022, an estimated $1.02M.
  • AbbVie made up 3.97% of Andrew Hill Investment Advisors's portfolio in Q3 2022, its #12 holding.
  • Andrew Hill Investment Advisors first reported a position in AbbVie in Q4 2021 and has held it in 4 quarters since.
  • Andrew Hill Investment Advisors's AbbVie position peaked at $5.44M in Q1 2022.
  • 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Andrew Hill Investment Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.